For patients with treatment-resistant major depressive disorder, deep transcranial magnetic stimulation significantly improved symptoms and quality of life compared with sham, according to a poster presented here. Aron Tendler, MD, chief medical officer of BrainsWay, a health technology company, presented the poster at the American Psychiatric Association annual meeting.
Read the full article.
